Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
Hebert Alberto Vargas, Gem Kramer, Andrew M. Scott, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 10, pp. 1516-1523
Open Access | Times Cited: 25

Showing 25 citing articles:

Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 61
Multimodality Imaging of Prostate Cancer
Soleen Ghafoor, Irene A. Burger, Alberto Vargas
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 10, pp. 1350-1358
Open Access | Times Cited: 67
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3
Joshua A. Korsen, Teja Kalidindi, Samantha Khitrov, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 9, pp. 1401-1407
Open Access | Times Cited: 30
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
Daniela E. Oprea‐Lager, Matthijs C. F. Cysouw, Ronald Boellaard, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer
Jiajie Fang, Ahmad Alhaskawi, Yanzhao Dong, et al.
Journal of Zhejiang University SCIENCE B (2025)
Closed Access
Three-dimensional architecture characteristics and diffusion properties of masticatory muscles assessed with diffusion tensor imaging and diffusion spectrum imaging: a pilot study of differences, reproducibility and sensitivity to microenvironment changes
Xiang Lin, Leyi Wei, Dejun She, et al.
BMC Musculoskeletal Disorders (2025) Vol. 26, Iss. 1
Open Access
Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review
Zhu Ming, Zhen Liang, Tianrui Feng, et al.
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2283-2283
Open Access | Times Cited: 10
Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone
B.H.E. Jansen, Gem Kramer, Matthijs C. F. Cysouw, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 8, pp. 1111-1117
Open Access | Times Cited: 26
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
B.H.E. Jansen, Matthijs C. F. Cysouw, André N. Vis, et al.
Journal of Nuclear Medicine (2020) Vol. 61, Iss. 9, pp. 1320-1325
Open Access | Times Cited: 24
Molecular Imaging of Steroid Receptors in Breast Cancer
Quinton Keigley, Amy M. Fowler, Sophia R. O’Brien, et al.
The Cancer Journal (2024) Vol. 30, Iss. 3, pp. 142-152
Closed Access | Times Cited: 2
Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer
Jorianne Boers, Clasina M. Venema, Erik F. J. de Vries, et al.
European Journal of Cancer (2020) Vol. 144, pp. 151-161
Open Access | Times Cited: 16
Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer
Luca Filippi, Viviana Frantellizzi, Agostino Chiaravalloti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3036-3036
Open Access | Times Cited: 15
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer
Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 6, pp. 863-868
Open Access | Times Cited: 6
Molecular Imaging of Recurrent and Metastatic Prostate Cancer
Robert E. Ware, Scott Williams, Rodney J. Hicks
Seminars in Nuclear Medicine (2019) Vol. 49, Iss. 4, pp. 280-293
Closed Access | Times Cited: 14
Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer
G. Krämer, Maqsood Yaqub, H. Alberto Vargas, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 9, pp. 1221-1227
Open Access | Times Cited: 12
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
Luca Filippi, Luca Urso, Orazio Schillaci, et al.
Diagnostics (2023) Vol. 13, Iss. 15, pp. 2613-2613
Open Access | Times Cited: 4
An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
Imke Schatka, Anne Bingel, F Schau, et al.
Journal of Nuclear Cardiology (2021) Vol. 28, Iss. 6, pp. 2483-2496
Open Access | Times Cited: 10
Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
Matthijs C. F. Cysouw, G. Krämer, Dennis Heijtel, et al.
EJNMMI Research (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-Dihydrotestosterone
Inês F. Antunes, Rutger J. Dost, Hilde Hoving, et al.
Journal of Nuclear Medicine (2021) Vol. 62, Iss. 8, pp. 1140-1145
Open Access | Times Cited: 9
Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
Mathieu Gauthé, Paul Sargos, Éric Barret, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4909-4909
Open Access | Times Cited: 6
Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module
Jin Li, Yixin Liu, Wenlei Dong, et al.
Quantitative Imaging in Medicine and Surgery (2021) Vol. 12, Iss. 3, pp. 1893-1908
Open Access | Times Cited: 4
Nuclear Receptor Imaging In Vivo—Clinical and Research Advances
Ephraim E. Parent, Amy M. Fowler
Journal of the Endocrine Society (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 3
[18F]FDHT tumour imaging for predicting response to treatment based on androgen receptor
Abdullah Mujahid Muhammad, Wenhao Dun, Zarif Ashhar, et al.
Journal of Radioanalytical and Nuclear Chemistry (2024) Vol. 333, Iss. 10, pp. 4631-4638
Closed Access
Prostate Cancer
Irene A. Burger, Daniela A. Ferraro, Matthias Friebe, et al.
Springer eBooks (2023), pp. 301-326
Closed Access
HAP-multitag, a PET and positive MRI contrast nanotracer for the longitudinal characterization of vascular calcifications in atherosclerosis
Juan Pellico, Irene Fernández‐Barahona, Jesús Ruíz‐Cabello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top